Pixelgen Raises $15.5 Million for Proxiome Kit Expansion

August 20, 2026
Pixelgen Technologies has closed a $15.5 million Series B round led by Flat Capital to expand commercialization of its Proxiome Kit and add software and data expertise to its board.

Pixelgen Technologies announced in a press release that it closed an oversubscribed $15.5 million Series B round to expand commercialization of its Proxiome Kit and grow in key markets. New investor Flat Capital led the round, with continued participation from Industrifonden and Navigare Ventures.

The Proxiome Kit maps molecular cell architecture at nanoscale resolution. It analyzes how proteins are organized, clustered, and localized on the surface of individual cells, rather than only measuring protein abundance.

Pixelgen said the financing will support global commercialization, hiring, and expansion of its product portfolio. The company is also adding Flat Capital CEO Rickard El Tarzi and Ramon Felciano, founder of Ingenuity Systems, to its board.

Felciano later worked at QIAGEN, where he helped form QIAGEN Digital Insights, a molecular data and AI software unit. At Pixelgen, he will work with leadership on software and data capabilities for the company’s molecular cell architecture platform.

We hope you enjoyed this article.

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more